Synonyms:
Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 9R2G075611

Structure

InChI Key IVUGFMLRJOCGAS-UHFFFAOYSA-N
Smile Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1
InChI
InChI=1S/C28H21N7OS/c1-17-15-24(37-16-17)25-20-5-2-3-6-21(20)26(35-34-25)32-18-8-10-19(11-9-18)36-27-22(7-4-13-30-27)23-12-14-31-28(29)33-23/h2-16H,1H3,(H,32,35)(H2,29,31,33)

Physicochemical Descriptors

Property Name Value
Molecular Formula C28H21N7OS
Molecular Weight 503.59
AlogP 6.64
Hydrogen Bond Acceptor 9.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 6.0
Polar Surface Area 111.73
Molecular species NEUTRAL
Aromatic Rings 6.0
Heavy Atoms 37.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Serine/threonine-protein kinase Aurora inhibitor PubMed PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Kinase Protein Kinase Other protein kinase group Other protein kinase AUR family
- 1 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials
Leukemia, Myeloid 1 D007951 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2140408
EPA CompTox DTXSID90241526
FDA SRS 9R2G075611
Guide to Pharmacology 8060
PubChem 24856041
SureChEMBL SCHEMBL503564
ZINC ZINC000043208325